Cover Image
Market Research Report

Europe Liposome Drug Delivery Market to 2027- Covid-19 Impact and Regional Analysis by Product ; Technology ; Application and Country

Published by The Insight Partners Product code 967110
Published Content info 124 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Liposome Drug Delivery Market to 2027- Covid-19 Impact and Regional Analysis by Product ; Technology ; Application and Country
Published: September 16, 2020 Content info: 124 Pages
Description

Title:
Europe Liposome Drug Delivery Market to 2027- Covid-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, and DepoFoam Liposome Technology); Application (Fungal Diseases, Pain Management, Cancer Therapy, Viral Vaccines, and Photodynamic Therapy) and Country.

The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast period.

The growing R&D expenditure on drug delivery, growing demand for non-invasive drug delivery devices. and the development of new lipid composition for stability and optimization of drugs are the major factors propelling the growth of the Europe liposome drug delivery market during the forecast period. High costs of R&D and impact of COVID-19 pandemic are likely to restrain the growth of the market during the forecast period.

Liposomes are a novel drug delivery system (NDDS) with a vesicular structure consisting of bilayers that is used to deliver drugs or genetic material into a cell. The aim of NDDS is to deliver the drug at a rate directed by the needs of the body during the period of treatment. Thus, companies in the liposome drug delivery market are capitalizing on this opportunity to increase their research in nanomaterials such as nanospheres, liposomes, and nanoparticles that are active antiviral agents. Liposome drug delivery is being leveraged with increased in vivo and in vitro drug activities for routine clinical practices.

The governments in European countries are encouraging the acceptance and adoption of liposomal drug deliver with an aim to streamline and improvise the process of drug delivery. It also provides a premier interdisciplinary platform for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered in application of amniotic membrane. Companies in the liposome drug delivery market are increasing their focus on drug delivery nanosystems involving major antiviral classes and their transport across specific barriers at a cellular and intracellular level. Thus, liposomes hold promising potentials in ongoing research studies being carried out by healthcare companies for the treatment of COVID-19.

Though, the major operations are badly hampered by the viral outbreak, some market players involved in the Europe liposome drug delivery market are coming forward to test the efficacy of liposome drug delivery against COVID-19. In the upcoming years, the research activities are expected to accelerate owing to their potential in treating wide range of diseases.

Based on the product, the Europe liposome drug delivery market was segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin segment held the highest share of the market, whereas, liposomal amphotericin B segment is expected to grow at the fastest rate during the forecast period.

Based on technology, the Europe liposome drug delivery market was segmented into stealth liposome technology, non-pegylated liposome technology, and depoFoam liposome technology. In 2019, stealth liposome technology segment held the largest share of the market and is anticipated to grow at the fastest rate during the forecast period.

Based on application, the Europe liposome drug delivery market was segmented into fungal diseases, pain management, cancer therapy, viral vaccines, and photo-dynamic therapy. In 2019, cancer therapy segment held the largest share of the market and the same segment is expected to grow at the fastest rate during the forecast period.

Some of the significant secondary sources for included in the report are European and Developing Countries Clinical Trials Partnership (EDCTP), Europa Bio, European Federation of Biotechnology (EFB), and Celsion Corporation.

Reasons to Buy:

Determine prospective investment areas based on a detailed trend analysis of the Europe Liposome Drug Delivery market over the next years.Gain an in-depth understanding of the underlying factors driving demand for different Liposome Drug Delivery segments in the top spending countries across the world and identify the opportunities offered by each of them.Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.Identify the major channels that are driving the Europe Liposome Drug Delivery market, providing a clear picture of future opportunities that will be helpful to Analyse, resulting in revenue expansion.Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the Europe Liposome Drug Delivery market

Table of Contents
Product Code: TIPRE00014191

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Liposome Drug Delivery Market - By product type
    • 1.3.2 Europe Liposome Drug Delivery Market - By Technology
    • 1.3.3 Europe Liposome Drug Delivery Market - By Application
    • 1.3.4 Europe Liposome Drug Delivery Market - By Country

2. Liposome Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Liposome Drug Delivery - Market Landscape

  • 4.1 Overview
    • 4.1.1 Europe- PEST Analysis
  • 4.2 Expert Opinion

5. Europe Liposome Drug Delivery Market - Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
    • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
  • 5.2 Market Restraints
    • 5.2.1 High Cost Involved in Development of Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
  • 5.4 Future Trends
    • 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Liposome Drug Delivery Market -Asia Pacific Analysis

  • 6.1 Europe Liposome Drug Delivery Market Revenue Forecast And Analysis

7. Liposome Drug Delivery Market Analysis - By Product

  • 7.1 Overview
  • 7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
  • 7.3 Liposomal Doxorubicin
    • 7.3.1 Overview
    • 7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Liposomal Paclitaxel
    • 7.4.1 Overview
    • 7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Liposomal Amphotericin B
    • 7.5.1 Overview
    • 7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Liposome Drug Delivery Market - By Technology

  • 8.1 Overview
  • 8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • 8.3 Stealth Liposome Technology
    • 8.3.1 Overview
    • 8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Non-PEGylated Liposome Technology
    • 8.4.1 Overview
    • 8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DepoFoam Liposome Technology
    • 8.5.1 Overview
    • 8.5.2 Depo Foam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
    • 8.6.1 Overview
    • 8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Liposome Drug Delivery Market - By Application

  • 9.1 Overview
  • 9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • 9.3 Fungal Diseases
    • 9.3.1 Overview
    • 9.3.2 Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Cancer Therapy
    • 9.4.1 Overview
    • 9.4.2 Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Pain Management
    • 9.5.1 Overview
    • 9.5.2 Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Viral Vaccine
    • 9.6.1 Overview
    • 9.6.2 Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Photodynamic Therapy
    • 9.7.1 Overview
    • 9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Liposome Drug Delivery Market - Geographic Analysis

  • 10.1 Europe: Liposome Drug Delivery Market
    • 10.1.1 Overview
    • 10.1.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.10 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.1 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.2 Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.3 Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.4 Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.11 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.1 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.2 Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.3 Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.4 Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic On European Liposome Drug Delivery Market

  • 11.1 Europe: Impact assessment of COVID-19 Pandemic

12. Liposome Drug Delivery Market -Company Profiles

  • 12.1 Takeda Pharmaceutical Company Limited
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novartis AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Luye Pharma Group
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Johnson & Johnson Services, Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ipsen Pharma
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Gilead Sciences, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Celsion, Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Astellas Pharma Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 7. United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 9. United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 10. France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 12. France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Glossary of Terms, Liposome Drug Delivery Market

List Of Figures

  • Figure 1. Liposome drug delivery Market Segmentation
  • Figure 2. Europe Liposome drug delivery Market
  • Figure 3. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market
  • Figure 4. Europe PEST Analysis
  • Figure 5. Europe Liposome Drug Delivery Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 6. Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
  • Figure 7. Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 8. Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 9. Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 10. Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 11. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • Figure 12. Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 14. Depo Foam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 15. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • Figure 17. Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Europe: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 23. Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 25. Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 26. UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 27. France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Impact of COVID-19 Pandemic In European Country Markets
Back to Top